Abstraction Form

Emergency Epidemic Investigation Data Collections - Expedited Reviews

Appendix 1. Abstraction Form

Undetermined risk factors for ocular syphilis - North Carolina, 2015

OMB: 0920-1011

Document [docx]
Download: docx | pdf


Form Approved

OMB No. 0920-1011

Exp. Date 03/31/2017















Name: ________________________________



North Carolina ID: ______________________



CDC ID: ______________________________

















CDC Study ID: ___________________________________







Charts Reviewed:



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted



Clinic: _________________________ Date of Visit: __ __- __ __- __ __ □ Chart Requested □ Chart Abstracted


















Date of syphilis diagnosis (mm/yyyy): __ __ - __ __ - __ __ __ __

Date of ocular syphilis diagnosis (mm/yyyy): __ __ - __ __ - __ __ __ ___


Demographics:


1: Patient’s sex
1: Male 2: Female 3: Transgender 4: Unknown

2: Patient’s age at time of diagnosis: __ __ __ years of age


3: Race/ethnicity:
1: White 2: Black 3: Hispanic or Latino 4: Asian
5: Native Hawaiian/Other Pacific Islander 6: American Indian or Alaska Native



Syphilis Information:


4: Does patient report or have documented history of syphilis prior to this episode?
1: Yes 2: No 3: Unknown

5: If Yes: Approximate date of previous syphilis infection: (mm-yyyy) __ __ - __ __ __ __


6: What stage of syphilis did patient have at time of ocular syphilis diagnosis?
1: Primary syphilis 2: Secondary syphilis 3: Early latent 4: Late latent

7: What was the patient’s syphilis serology result at the time of ocular syphilis diagnosis? Please circle “Yes” for all tests performed and provide test result and date of test

RPR Yes No Result (titer): Date of test: mm/dd/yyyy

VDRL Yes No Result (titer): Date of test: : mm/dd/yyyy

EIA Yes No Result: Date of test: : mm/dd/yyyy

TP-PA Yes No Result: Date of test: : mm/dd/yyyy

FTA-ABS Yes No Result: Date of test: mm/dd/yyyy

Other- Type of test: Result: Date of test: mm/dd/yyyy


8: Did the patient have or report recent history of any symptoms that could be associated with primary or secondary syphilis?
1: Yes 2: No 3: Unknown


9: If yes, please detail symptoms patient reported: Choose as many as apply:
1: Chancre/genital lesion 2: Skin rash 3: Lymphadenopathy/swollen lymph nodes
4: Alopecia 5: Other: _____________________________________________________


10: Did the patient have a diagnosis of neurosyphilis?

1: Yes 2: No 3: Unknown


11: Did the patient have any extraocular neurologic symptoms?
1: Yes 2: No 3: Unknown


12: If yes, please detail neurologic symptoms patient reported: (e.g. headache, neck stiffness): __________________________________________________________________________________________


13: Did patient have a lumbar puncture (LP) performed?
1: Yes 2: No 3: Unknown


14: If yes LP was performed please answer the following questions:
1: CSF VDRL result ____________________

2: CSF FTA-abs ____________________

3: CSF WBC ____________________
4: CSF total protein ____________________

5: CSF glucose ____________________


15: What treatment did patient receive and what was the duration?
1: Benzathine penicillin G Doses _____________________
2: Aqueous crystalline penicillin G IV Duration (days) ____________
3: Procaine penicillin Duration (days)_____________
4: Ceftriaxone 2 g daily either IM or IV Doses _____________________
5: Other _______________________________


HIV Information:


16: Patient’s HIV status:
1: HIV-infected Approximate year of diagnosis (yyyy) __ __ __ __
2: HIV-uninfected Date of most recent negative HIV test if known: (mm-yyyy) __ __ - __ __ __ __
3: Unknown


17: If HIV-uninfected, was the patient on PrEP?
1: Yes 2: No 3: Unknown


Question 6-8: If HIV-infected:

18: Was this a new diagnosis, concurrent with syphilis diagnosis?
1: Yes 2: No 3: Unknown

19: Was patient on cART at time of diagnosis?
1: Yes 2: No 3: Unknown


20: Patient’s most recent CD4 count: _____________


21: Patient’s most recent viral load: ______________

22: What HIV medication has the patient been on in the last 5 years:

Medication: _____________________________ Dates on medication: ______________________
Medication: _____________________________ Dates on medication: ______________________
Medication: _____________________________ Dates on medication: ______________________
Medication: _____________________________ Dates on medication: ______________________
Medication: _____________________________ Dates on medication: ______________________



23: During the course of this illness, where did the patient seek treatment?
1: STD or HIV Clinic 2: Infectious Disease Clinic 3: Eye Clinic
4: Emergency Room 5: Primary Care Clinic 6: Admitted as inpatient






Sexual Behavior Questions:


24: Gender of the patient’s sexual partners
1: Men only 2: Women only 3: Both men and women 4: Unknown


If patient reports MSM behavior:

25: In the past 12 months, with how many different men has the patient had oral or anal sex? _____ _____ _____

26: In the past 12 months, with how many different men has the patient had anal sex? _____ _____ _____


27: In the past 12 months, with how many different men has the patient had oral sex? _____ _____ _____


28: How often does the patient say they use condoms?

1: All/most of the time 2: Some of the time 3: Never or almost never


29: In the past 12 months, has the patient exchanged drugs or money for sex?
1: Yes 2: No 3: Unknown


30: Does the patient report using the internet or apps/social media to meet sexual partners?
1: Yes 2: No 3: Unknown


31: (Females only). In the past 12 months, has the patient had sex with a person who is known to her to be an MSM?
1: Yes 2: No 3: Unknown


32: In the past 12 months, has the patient engaged in injection drug use?
1: Yes 2: No 3: Unknown


33: In the past 12 months, has the patient used any of the following injection or non-injection drug?
1: Crack 2: Cocaine 3: Heroin 4: Nitrates/Poppers 5: Methamphetamines

6: Other: _________________________________________________________________________________


34: In the past 12 months has the patient used erectile dysfunction medications?

1: Yes 2: No 3: Unknown


35: In the past 12 months, has the patient been incarcerated?
1: Yes 2: No 3: Unknown


36: In the past 12 months, has the patient been diagnosed with another STD?
1: Yes 2: No 3: Unknown


37: If yes: what was patient diagnosed with:
1: Syphilis 2: Gonorrhea 3: Chlamydia 4: Trichomonas 5: HSV


38: In the past 12 months, has the patient traveled?
1: Yes, but only within the United States 2: Yes, internationally 3: No 4: Unknown


39: If yes to travel, do they report sexual contacts during the travel?
1: Yes 2: No 3: Unknown


Ophthalmologic Exam:


40: Did the patient have an ophthalmologic exam?
1: Yes 2: No 3: Unknown


41: Date of first ophthalmologic exam: (mm-dd-yyyy) __ __-__ __-__ __ __ __


42: What were the patient’s ocular symptoms?
Choose as many as apply. Please detail, including length of symptoms.
1: Eye pain Details: _____________________________________________
2: Red eye Details: _____________________________________________
3: Blurry vision/Change in vision Details: _____________________________________________
4: Partial vision loss Details: _____________________________________________
5: Loss of functional vision in 1 eye Details: _____________________________________________
6: Loss of function vision in both eyes Details: _____________________________________________
7: Other visual symptoms Details: _____________________________________________
8: Unknown


43: Detail pertinent findings, diagnoses and date of exam:
Choose as many as apply:
1: Scleritis/Keratitis Details: _________________

2: Uveitis: Details: _________________
3: Chorioretinitis Details: _________________
4: Optic Neuritis Details: _________________
5: Retinal Detachment Details: _________________
6: Other ocular findings Details: ________________________________________________________

44: If yes to Uveitis, was it:

1: Anterior Uveitis 2: Posterior Uveitis 3: Panuveitis

45: What was the patient’s visual acuity at presentation?

1: Left eye: 20/________
2: Right eye: 20/________


46: Which eye was involved?
1: Left eye only 2: Right eye only 3: Both eyes 4: Unknown




Follow-up Ophthalmologic Exam:


47: Did the patient have a follow up eye exam(s)?

1: Yes 2: No 3: Unknown


48: Date of most recent follow up ophthalmologic exam: (mm-dd-yyyy) __ __-__ __-__ __ __ __


49: What was the patient’s visual acuity at most recent follow-up?
1: Left eye: 20/________
2: Right eye: 20/________


50: Did the patient’s ocular symptoms improve following treatment?
1: Yes, symptoms completely resolved 2: Yes, but still with residual deficit 3: No

Public reporting burden of this collection of information is estimated to average 90 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer; 1600 Clifton Road NE, MS D-74 Atlanta, Georgia 30333; ATTN: PRA (0920-1011)

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorOliver, Sara Elizabeth (CDC)
File Modified0000-00-00
File Created2021-01-24

© 2024 OMB.report | Privacy Policy